keyword
https://read.qxmd.com/read/35839844/chronic-rhinosinusitis-is-associated-with-non-cystic-fibrosis-bronchiectasis-a%C3%A2-new-clinical-implication
#41
EDITORIAL
Jarkko Mäntylä, Paula Kauppi, Sanna Toppila-Salmi
No abstract text is available yet for this article.
September 2022: Journal of Allergy and Clinical Immunology
https://read.qxmd.com/read/35813823/multifaceted-roles-of-ferroptosis-in-lung-diseases
#42
REVIEW
Yi Li, Ying Yang, Yongfeng Yang
Ferroptosis is a distinct type of programmed cell death (PCD) that depends on iron and is characterized by the accumulation of intracellular iron, exhaustion of glutathione, deactivation of glutathione peroxidase, and promotion of lipid peroxidation. Recently, accumulated investigations have demonstrated that ferroptosis is strongly correlated with the initiation and development of many lung diseases. In this review, we summarized the contribution of ferroptosis to the pathologic process of lung diseases, namely, obstructive lung diseases (chronic obstructive pulmonary disease, asthma, and cystic fibrosis), interstitial lung diseases (pulmonary fibrosis of different causes), pulmonary diseases of vascular origin (ischemia-reperfusion injury and pulmonary hypertension), pulmonary infections (bacteria, viruses, and fungi), acute lung injury, acute respiratory distress syndrome, obstructive sleep apnea, pulmonary alveolar proteinosis, and lung cancer...
2022: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/35779240/pediatric-pulmonary-year-in-review-2021-sleep-medicine
#43
REVIEW
Caroline U A Okorie, Olufunke Afolabi-Brown, Ignacio E Tapia
Pediatric pulmonology publishes original research, review articles, and case reports on a wide variety of pediatric respiratory disorders. In this article, we summarized the past year's publications in sleep medicine and reviewed selected literature from other journals in this field. We focused on original research articles exploring aspects of sleep-disordered breathing in patients with underlying conditions such as cystic fibrosis, asthma, and sickle cell disease. We also explored sleep-disordered breathing risk factors, monitoring, diagnosis, and treatment; and included recent recommendations for drug-induced sleep endoscopy and ways to monitor and improve PAP adherence remotely...
July 2, 2022: Pediatric Pulmonology
https://read.qxmd.com/read/35742382/sleep-sedentary-time-and-physical-activity-levels-in-children-with-cystic-fibrosis
#44
JOURNAL ARTICLE
Mayara S Bianchim, Melitta A McNarry, Alan R Barker, Craig A Williams, Sarah Denford, Anne E Holland, Narelle S Cox, Julianna Dreger, Rachel Evans, Lena Thia, Kelly A Mackintosh
The aim of this study was to compare the use of generic and cystic fibrosis (CF)-specific cut-points to assess movement behaviours in children and adolescents with CF. Physical activity (PA) was assessed for seven consecutive days using a non-dominant wrist-worn ActiGraph GT9X in 71 children and adolescents (36 girls; 13.5 ± 2.9 years) with mild CF. CF-specific and generic Euclidean norm minus one (ENMO) cut-points were used to determine sedentary time (SED), sleep, light physical activity (LPA), moderate physical activity and vigorous physical activity...
June 10, 2022: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/35615416/ers-international-congress-2021-highlights-from-the-paediatric-assembly
#45
REVIEW
Cristina Ardura-Garcia, Alicia Abellan, Sara Cuevas-Ocaña, Nadine Freitag, Yin Ting Lam, Heidi Makrinioti, Monique Slaats, Matteo Storti, Emma E Williams, Theodore Dassios, Liesbeth Duijts, Refika H Ersu, Stojka Fustik, Rory E Morty, Marijke Proesmans, Dirk Schramm, Sejal Saglani, Alexander Moeller, Marielle W Pijnenburg
In this review, Early Career Members of the European Respiratory Society (ERS) and the Chairs of the ERS Assembly 7: Paediatrics present the highlights in paediatric respiratory medicine from the ERS International Congress 2021. The eight scientific Groups of this Assembly cover respiratory physiology and sleep, asthma and allergy, cystic fibrosis (CF), respiratory infection and immunology, neonatology and intensive care, respiratory epidemiology, bronchology, and lung and airway development. We here describe new developments in lung function testing and sleep-disordered breathing diagnosis, early life exposures affecting pulmonary function in children and effect of COVID-19 on sleep and lung function...
April 2022: ERJ Open Research
https://read.qxmd.com/read/35598598/effect-of-triple-combination-cftr-modulator-therapy-on-sleep-in-adult-patients-with-cystic-fibrosis
#46
JOURNAL ARTICLE
Matthias Welsner, Tim Schulte, Sarah Dietz-Terjung, Gerhard Weinreich, Florian Stehling, Christian Taube, Svenja Strassburg, Christoph Schoebel, Sivagurunathan Sutharsan
BACKGROUND: Sleep-disordered breathing (SDB) and disturbed sleep are common, often underrecognized, comorbidities in people with cystic fibrosis (pwCF). OBJECTIVES: We studied the effect of CFTR triple combination therapy elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) on sleep in pwCF. METHOD: This was a prospective, observational sleep study in clinically stable adult pwCF. All participants underwent overnight polysomnography (PSG), before (T0) and after (T1) initiation of CFTR modulator therapy with ELX/TEZ/IVA...
2022: Respiration; International Review of Thoracic Diseases
https://read.qxmd.com/read/35564550/a-compositional-analysis-of-physical-activity-sedentary-time-and-sleep-and-associated-health-outcomes-in-children-and-adults-with-cystic-fibrosis
#47
JOURNAL ARTICLE
Mayara S Bianchim, Melitta A McNarry, Anne Holland, Narelle S Cox, Julianna Dreger, Alan R Barker, Craig A Williams, Sarah Denford, Kelly A Mackintosh
This study sought to investigate the association of light physical activity (LPA), moderate-to-vigorous physical activity (MVPA), sedentary time (SED), and sleep with lung function in children and adults with CF. In total, 86 children (41 females; 13.6 ± 2.8 years; FEV1 %predicted : 86 ± 1%) and 43 adults (21 females; 24.6 ± 4.7 years; FEV1 %predicted : 63 ± 21%) with CF participated in this study. Wrist-worn accelerometery was used to assess PA, SED and sleep. Compositional linear regression models were conducted following normalisation via isometric log-ratio transformations...
April 23, 2022: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/35501222/short-and-long-term-impact-of-covid-19-infection-on-previous-respiratory-diseases
#48
REVIEW
Eusebi Chiner-Vives, Rosa Cordovilla-Pérez, David de la Rosa-Carrillo, Marta García-Clemente, José Luis Izquierdo-Alonso, Remedios Otero-Candelera, Luis Pérez-de Llano, Jacobo Sellares-Torres, José Ignacio de Granda-Orive
On March 11, 2020, the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18 million) persons all over the world with a total of 6.04 million of deaths (Spain, 100,992). It is observed that 75% of hospitalized COVID-19 patients have at least one COVID-19 associated comorbidity. It was shown that people with underlying chronic illnesses are more likely to get it and grow seriously ill. Individuals with COVID-19 who have a past medical history of cardiovascular disorder, cancer, obesity, chronic lung disease, diabetes, or neurological disease had the worst prognosis and are more likely to develop acute respiratory distress syndrome or pneumonia...
April 2022: Archivos de Bronconeumología
https://read.qxmd.com/read/35312523/-translated-article-biological-biomarkers-in-respiratory-diseases
#49
REVIEW
Francisco García-Río, Bernardino Alcázar-Navarrete, Diego Castillo-Villegas, Catia Cilloniz, Alberto García-Ortega, Virginia Leiro-Fernández, Irene Lojo-Rodriguez, Alicia Padilla-Galo, Carlos A Quezada-Loaiza, Jose Antonio Rodriguez-Portal, Manuel Sánchez-de-la-Torre, Oriol Sibila, Miguel A Martínez-García
In recent years, personalized or precision medicine has made effective inroads into the management of diseases, including respiratory diseases. The route to implementing this approach must invariably start with the identification and validation of biological biomarkers that are closely related to the diagnosis, treatment, and prognosis of respiratory patients. In this respect, biological biomarkers of greater or lesser reliability have been identified for most respiratory diseases and disease classes, and a large number of studies are being conducted in the search for new indicators...
April 2022: Archivos de Bronconeumología
https://read.qxmd.com/read/35312522/biological-biomarkers-in-respiratory-diseases
#50
REVIEW
Francisco García-Río, Bernardino Alcázar-Navarrete, Diego Castillo-Villegas, Catia Cilloniz, Alberto García-Ortega, Virginia Leiro-Fernández, Irene Lojo-Rodriguez, Alicia Padilla-Galo, Carlos A Quezada-Loaiza, Jose Antonio Rodriguez-Portal, Manuel Sánchez-de-la-Torre, Oriol Sibila, Miguel A Martínez-García
In recent years, personalized or precision medicine has made effective inroads into the management of diseases, including respiratory diseases. The route to implementing this approach must invariably start with the identification and validation of biological biomarkers that are closely related to the diagnosis, treatment, and prognosis of respiratory patients. In this respect, biological biomarkers of greater or lesser reliability have been identified for most respiratory diseases and disease classes, and a large number of studies are being conducted in the search for new indicators...
April 2022: Archivos de Bronconeumología
https://read.qxmd.com/read/35143153/childhood-respiratory-conditions-nonasthma-chronic-lung-disease
#51
JOURNAL ARTICLE
Cori Daines
Bronchopulmonary dysplasia (BPD) is a chronic lung disease that results from impaired lung development or lung injury from ventilatory support. It primarily is seen in infants born prematurely. Approximately 95% of infants with BPD had a low birth weight (ie, less than 1,500 g). This condition affects pulmonary function throughout the life span. Many children with BPD develop asthmalike symptoms with recurrent wheezing beginning in the preschool-aged years. Complications include pulmonary hypertension, tracheomalacia, glottic damage, sleep apnea, and more frequent and/or severe respiratory infections...
February 2022: FP Essentials
https://read.qxmd.com/read/35110251/the-frequency-of-obstructive-sleep-apnea-in-patients-with-non-cystic-fibrosis-bronchiectasis
#52
JOURNAL ARTICLE
Sermin Borekci, Yonca Sekibag, Deniz Ongel Harbiyeli, Benan Musellim
OBJECTIVE: Interruption or reduction in airflow and desaturation is a theoretically expected result in bronchiectasis accompanied by excessive secretions in the airways, bronchial wall thickening, and destruction of the wall structure. The same mechanism of interruption or reduction in airflow and desaturation is valid for obstructive sleep apnea (OSA). However, data on the association of bronchiectasis with OSA are scarce. We aimed to investigate the frequency of OSA and related parameters in patients with non-cystic fibrosis bronchiectasis (NCFB)...
July 2021: Turkish Thoracic Journal
https://read.qxmd.com/read/34967157/risk-factors-for-obstructive-sleep-apnea-in-cystic-fibrosis
#53
JOURNAL ARTICLE
Aarti Shakkottai, Sanaya Irani, Samya Z Nasr, Louise M O'Brien, Ronald D Chervin
INTRODUCTION: Despite emerging data that suggest a high frequency and severity of obstructive sleep apnea (OSA) among patients with cystic fibrosis (CF), few of them are referred for polysomnography. Little is known about which patients with CF are at increased risk for OSA and which sleep symptoms merit investigation. METHODS: A single-center retrospective analysis of clinical and polysomnographic data from 2009, January 1 to October 31, 2020 in referred children and adults with CF...
April 2022: Pediatric Pulmonology
https://read.qxmd.com/read/34936085/interventions-for-preventing-distal-intestinal-obstruction-syndrome-dios-in-cystic-fibrosis
#54
REVIEW
Will Carroll, Jessica Green, Francis J Gilchrist
BACKGROUND: Cystic fibrosis (CF) is the most common, life-limiting, genetically inherited disease. It affects multiple organs, particularly the respiratory system. However, gastrointestinal problems such as constipation and distal intestinal obstruction syndrome (DIOS) are also important and well-recognised complications in CF. They share similar symptoms e.g. bloating, abdominal pain, but are distinct conditions. Constipation occurs when there is gradual faecal impaction of the colon, but DIOS occurs when there is an accumulation of faeces and sticky mucus, forming a mass in the distal part of the small intestine...
December 22, 2021: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/34887326/clinical-validation-of-digital-biomarkers-for-paediatric-patients-with-asthma-and-cystic-fibrosis-potential-for-clinical-trials-and-clinical-care
#55
JOURNAL ARTICLE
Matthijs D Kruizinga, Esmée Essers, Frederik E Stuurman, Yalçin Yavuz, Marieke L de Kam, Ahnjili Zhuparris, Hettie M Janssens, Iris Groothuis, Arwen J Sprij, Marianne Nuijsink, Adam F Cohen, Gertjan J A Driessen
BACKGROUND: Digital biomarkers are a promising novel method to capture clinical data in a home setting. However, clinical validation prior to implementation is of vital importance. The aim of this study was to clinically validate physical activity, heart rate, sleep and forced expiratory volume in 1 s (FEV1 ) as digital biomarkers measured by a smartwatch and portable spirometer in children with asthma and cystic fibrosis (CF). METHODS: This was a prospective cohort study including 60 children with asthma and 30 children with CF (aged 6-16 years)...
June 2022: European Respiratory Journal
https://read.qxmd.com/read/34833630/future-trends-in-semiconducting-gas-selective-sensing-probes-for-skin-diagnostics
#56
JOURNAL ARTICLE
Anthony Annerino, Pelagia-Irene Perena Gouma
This paper presents sensor nanotechnologies that can be used for the skin-based gas "smelling" of disease. Skin testing may provide rapid and reliable results, using specific "fingerprints" or unique patterns for a variety of diseases and conditions. These can include metabolic diseases, such as diabetes and cholesterol-induced heart disease; neurological diseases, such as Alzheimer's and Parkinson's; quality of life conditions, such as obesity and sleep apnea; pulmonary diseases, such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease; gastrointestinal tract diseases, such as irritable bowel syndrome and colitis; cancers, such as breast, lung, pancreatic, and colon cancers; infectious diseases, such as the flu and COVID-19; as well as diseases commonly found in ICU patients, such as urinary tract infections, pneumonia, and infections of the blood stream...
November 13, 2021: Sensors
https://read.qxmd.com/read/34815328/physical-activity-and-sedentary-behavior-in-adults-with-cystic-fibrosis-association-with-aerobic-capacity-lung-function-sleep-well-being-and-quality-of-life
#57
JOURNAL ARTICLE
Máire Curran, Audrey C Tierney, Brenda Button, Louise Collins, Lauren Kennedy, Ciara McDonnell, Ali Sheikhi, Andrew Jurascheck, Brian Casserly, Roisin Cahalan
BACKGROUND: Physical activity (PA) and sedentary behavior (SB) have marked impact on key prognostic indicators such as aerobic capacity and lung function in people with cystic fibrosis (CF) and may have associations with sleep, well-being, and health-related quality of life (HRQOL). METHODS: This observational study assessed PA, SB, aerobic capacity, spirometry, sleep, well-being, and HRQOL in adults with CF at University Hospital Limerick. PA and SB were assessed using an accelerometer that was worn for 7 days...
March 2022: Respiratory Care
https://read.qxmd.com/read/34789668/abdominal-symptoms-assessed-with-the-cfabd-score-are-associated-with-intestinal-inflammation-in-patients-with-cystic-fibrosis
#58
JOURNAL ARTICLE
Anke Jaudszus, Elena Pfeifer, Michael Lorenz, Nathalie Beiersdorf, Uta Christina Hipler, Carlos Zagoya, Jochen G Mainz
OBJECTIVES: This prospective study evaluated the relationship between fecal markers of intestinal inflammation and cystic fibrosis (CF)-associated abdominal symptoms. These were assessed using the CFAbd-Score, a CF-specific patient-related outcome measure developed and validated, following FDA guidelines. METHODS: In feces from patients with CF (n = 41) and healthy volunteers (n = 27), concentrations of fecal calprotectin (FC), M2-pyruvate kinase (M2-PK), interleukins IL-1β, IL-6, IL-8, and neutrophilic elastase (NE) were measured...
March 1, 2022: Journal of Pediatric Gastroenterology and Nutrition
https://read.qxmd.com/read/34751000/an-overview-of-noninvasive-ventilation-in-cystic-fibrosis
#59
REVIEW
Aesha Jobanputra, Sugeet Jagpal, Paula Marulanda, Maya Ramagopal, Teodoro Santiago, Sreelatha Naik
Noninvasive ventilation (NIV) use was initially reported in cystic fibrosis (CF) in 1991 as a bridge to lung transplantation, and over the decades, the use of NIV has increased in the CF population. Individuals with CF are prone to various physiologic changes as lung function worsens, and they benefit from NIV for advanced lung disease. As life expectancy in CF has been increasing due to advances such as highly effective modulator therapy, people with CF may also benefit from NIV for other diagnosis beyond advanced lung disease...
February 2022: Pediatric Pulmonology
https://read.qxmd.com/read/34731826/obstructive-sleep-apnea-in-children-and-adolescents-with-cystic-fibrosis-and-preserved-lung-function-or-mild-impairment-a-systematic-review-and-meta-analysis-of-prevalence
#60
REVIEW
Luisa Pedrada de Sousa, Fernanda Mayrink Gonçalves Liberato, Fernanda Maria Vendrusculo, Márcio Vinícius Fagundes Donadio, Roberta Ribeiro Batista Barbosa
OBJECTIVE/BACKGROUND: Sleep disorders in cystic fibrosis may be present before daytime clinical manifestations, regardless of lung function impairment, affecting quality of life and disease progression. This study investigated the prevalence of obstructive sleep apnea in children and adolescents with cystic fibrosis and preserved lung function or mild impairment, and evaluated its association with clinical variables. METHODS: A systematic review with meta-analysis of prevalence was conducted, including observational studies with polysomnographies in patients with cystic fibrosis who presented mean lung function values > 60% predicted...
October 1, 2021: Sleep Medicine
keyword
keyword
12855
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.